Simon Baker CFA
Stock Analyst at Rothschild & Co Redburn
(0.99)
# 3,859
Out of 5,000 analysts
17
Total ratings
38.5%
Success rate
-5.2%
Average return
Main Sectors:
Stocks Rated by Simon Baker CFA
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MRNA Moderna | Downgraded: Sell | $81 | $194.82 | -58.42% | 2 | Sep 3, 2026 | |
| NVO Novo Nordisk | Upgraded: Buy | n/a | $38.62 | n/a | 2 | Sep 16, 2025 | |
| GILD Gilead Sciences | Reiterated: Buy | $143 | $149.69 | n/a | 1 | Sep 12, 2025 | |
| REGN Regeneron Pharmaceuticals | Initiated Coverage: Buy | $890 | $796.02 | n/a | 1 | Aug 14, 2025 | |
| AUTL Autolus Therapeutics | Upgraded: Buy | $13 | $1.91 | n/a | 1 | Nov 15, 2024 | |
| EPA: IPN Ipsen S.A. | Reiterated: Buy | €165.00 | €149.10 | n/a | 1 | Jun 15, 2024 | |
| SWX: NOVN Novartis AG | Downgraded: Sell | CHF 105.00 → CHF 80.00 | CHF 118.96 | n/a | 3 | Nov 27, 2023 | |
| BNTX BioNTech SE | Upgraded: Buy | $170 | $99.26 | n/a | 3 | May 17, 2023 | |
| ABT Abbott Laboratories | Initiated Coverage: Hold | n/a | $101.07 | n/a | 1 | Oct 14, 2021 | |
| QGEN Qiagen | Initiated Coverage: Buy | n/a | $44.56 | n/a | 1 | Oct 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $363.40 | n/a | 1 | Apr 1, 2020 |
Moderna
Sep 3, 2026
Downgraded: Sell
Price Target: $81
Current: $194.82
Upside: -58.42%
Novo Nordisk
Sep 16, 2025
Upgraded: Buy
Price Target: n/a
Current: $38.62
Upside: n/a
Gilead Sciences
Sep 12, 2025
Reiterated: Buy
Price Target: $143
Current: $149.69
Upside: n/a
Regeneron Pharmaceuticals
Aug 14, 2025
Initiated Coverage: Buy
Price Target: $890
Current: $796.02
Upside: n/a
Autolus Therapeutics
Nov 15, 2024
Upgraded: Buy
Price Target: $13
Current: $1.91
Upside: n/a
Ipsen S.A.
Jun 15, 2024
Reiterated: Buy
Price Target: €165.00
Current: €149.10
Upside: n/a
Novartis AG
Nov 27, 2023
Downgraded: Sell
Price Target: CHF 105.00 → CHF 80.00
Current: CHF 118.96
Upside: n/a
BioNTech SE
May 17, 2023
Upgraded: Buy
Price Target: $170
Current: $99.26
Upside: n/a
Abbott Laboratories
Oct 14, 2021
Initiated Coverage: Hold
Price Target: n/a
Current: $101.07
Upside: n/a
Qiagen
Oct 14, 2021
Initiated Coverage: Buy
Price Target: n/a
Current: $44.56
Upside: n/a
Apr 1, 2020
Upgraded: Buy
Price Target: n/a
Current: $363.40
Upside: n/a